Earnings Beat: Social media chatter intensified after Claritev posted robust second-quarter results that surpassed analyst projections on both revenue and EBITDA. Observers highlighted the company's decision to lift its full-year 2026 guidance as a key driver of renewed interest. The announcement sparked widespread commentary on the firm's operational momentum.
Market Reaction: Market participants described an immediate and sharp upward move in the share price, with the stock advancing nearly 30 percent in a single session. Discussions focused on the volume surge and how the positive data point shifted broader sentiment toward the name. Some noted continued follow-through buying in subsequent sessions.
Ongoing Dialogue: Traders continued to track the name's performance, citing ongoing gains layered on top of the initial rally. The tone across platforms remained focused on the earnings catalyst and its implications for near-term momentum. Overall sentiment stayed firmly positive amid the fresh data release.
Note: This discussion summary was generated from an AI condensation of post data.
Claritev Insider Trading Activity
Claritev insiders have traded $CTEV stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CTEV stock by insiders over the last 6 months:
- MICHAEL KIM (EVP, Chief Digital Officer) has made 2 purchases buying 45,000 shares for an estimated $676,455 and 0 sales.
- TRAVIS DALTON (Pres., CEO & Executive Chair) purchased 15,380 shares for an estimated $199,927
- NUTTER CAROL (SVP, Chief People Officer) purchased 875 shares for an estimated $24,856
- DOUGLAS MICHAEL GARIS (EVP&CFO) purchased 1,300 shares for an estimated $22,997
- TARA O'NEIL (SVP, General Counsel) purchased 750 shares for an estimated $9,742
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Claritev Revenue
Claritev had revenues of $257.5M in Q2 2026. This is an increase of 6.59% from the same period in the prior year.
You can track CTEV financials on Quiver Quantitative's CTEV stock page.
You can access data on CTEV stock through the Quiver Quantitative API.
Claritev Hedge Fund Activity
We have seen 54 institutional investors add shares of Claritev stock to their portfolio, and 43 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BARCLAYS PLC added 229,990 shares (+1950.2%) to their portfolio in Q1 2026, for an estimated $3,758,036
- TOPLINE CAPITAL MANAGEMENT, LLC removed 196,718 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $3,214,372
- BLACKROCK, INC. added 135,214 shares (+23.0%) to their portfolio in Q2 2026, for an estimated $4,612,149
- MILLENNIUM MANAGEMENT LLC removed 113,818 shares (-85.5%) from their portfolio in Q1 2026, for an estimated $1,859,786
- CASPIAN CAPITAL LP added 106,250 shares (+42.5%) to their portfolio in Q1 2026, for an estimated $1,736,125
- THIRD POINT LLC removed 101,000 shares (-69.7%) from their portfolio in Q1 2026, for an estimated $1,650,340
- SCOGGIN MANAGEMENT LP added 88,523 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,446,465
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Claritev Price Targets
Multiple analysts have issued price targets for $CTEV recently. We have seen 5 analysts offer price targets for $CTEV in the last 6 months, with a median target of $28.0.
Here are some recent targets:
- Richard Close from Canaccord Genuity set a target price of $32.0 on 05/29/2026
- Glen Santangelo from Barclays set a target price of $28.0 on 04/24/2026
- Stan Berenshteyn from Wells Fargo set a target price of $22.0 on 03/19/2026
- Daniel Grosslight from Citigroup set a target price of $21.0 on 02/25/2026
- Jason Cassorla from Guggenheim set a target price of $38.0 on 02/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
